|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not
intended to be used as a source of information on on healthcare or medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines
or the package leaflet of your medicine. For up-to-date information on other
healthcare topics, please consult the relevant reliable sources or an healthcare
expert, such as a physician etc.
|
BACK TO LIST |
European Patient Summary
|
|
|
|||||||||||||||||||
Problem list
| Condition | Onset Date / Period | Status |
|---|---|---|
| Obstructive sleep apnea syndrome | 27-Aug-2022 | active |
| Sleep disorder | 26-Jul-2022 | active |
| Fibromyalgia | 06-Feb-2014 | active |
| Essential hypertension | 13-Aug-2013 | active |
| Anemia | 30-Oct-2007 | active |
| Recurrent urinary tract infection | 08-Dec-1988 | active |
| Chronic sinusitis | 01-Apr-1975 | active |
| Acute viral pharyngitis | 04-Nov-2023 - 14-Nov-2023 | inactive |
| Acute bronchitis | 16-Mar-2021 - 04-Apr-2021 | inactive |
| Acute viral pharyngitis | 03-Mar-2021 - 16-Mar-2021 | inactive |
| Acute viral pharyngitis | 22-Dec-2019 - 05-Jan-2020 | inactive |
| Acute viral pharyngitis | 29-Dec-2015 - 10-Jan-2016 | inactive |
Medication list
| Medication | Since | Form | Dosage | Reason |
|---|---|---|---|---|
| Ibuprofen 400 mg oral tablet | 2024-10-15 | - | 1 tablet (400 mg) by mouth every 6 hours as needed | - |
| Amlodipine (as amlodipine besylate) 2.5 mg oral tablet | 2024-10-15 | - | 1 tablet (2.5 mg) by mouth once daily | Essential hypertension (disorder) |
Immunizations list
| Vaccine | Date |
|---|---|
| Clostridium tetani toxoid antigen adsorbed only vaccine product | 15-Oct-2024 |
| Live attenuated Human alphaherpesvirus 3 only vaccine product | 15-Oct-2024 |
| Influenza virus antigen only vaccine product | 15-Oct-2024 |
| SARS-CoV-2 mRNA vaccine | 31-Aug-2021 |
Procedure History list
| Procedure | Date | Reason |
|---|---|---|
| Sleep apnea monitoring with alarm | 27-Aug-2022 | Sleep disorder (disorder) |
| Sleep apnea assessment | 27-Aug-2022 | Sleep disorder (disorder) |
Allergies and Intolerances
| No known allergies or intolerances |
Care Plan
| Active Planned Care / Goals | Start Date | Reason |
|---|---|---|
| Care plan | 27-Aug-2022 | Obstructive sleep apnea syndrome (disorder) |
|
||
| Lifestyle education regarding hypertension | 13-Aug-2013 | Essential hypertension (disorder) |
|
||
| Diabetes self management plan | 26-Oct-2004 | Prediabetes (finding) |
|
Vital Signs
| Vital Signs | 2024-10-15 | 2023-11-03 |
|---|---|---|
| Body Height | 158.8 cm | - |
| Pain severity - 0-10 verbal numeric rating [Score] - Reported | 0 {score} | - |
| Body Weight | 60.2 kg | - |
| Body mass index (BMI) [Ratio] | 23.9 kg/m2 | - |
| Heart rate | 87 /min | - |
| Respiratory rate | 13 /min | - |
| Blood pressure panel with all children optional | 114 mm[Hg] | - |
| Body temperature | - | 37.9 Cel |
Relevant diagnostic tests/laboratory data
| Recent Lab Observations | 15-OCT-2024 | Reference Range | Unit |
|---|---|---|---|
| Hemoglobin A1c/Hemoglobin.total in Blood | 6.1 H | 4.0 - 5.6 | % |
| Glucose [Mass/volume] in Blood | 67.7 L | 70 - 100 | mg/dL |
| Urea nitrogen [Mass/volume] in Blood | 11.7 | 7 - 20 | mg/dL |
| Creatinine [Mass/volume] in Blood | 0.6 | 0.5 - 1.1 | mg/dL |
| Calcium [Mass/volume] in Blood | 9.8 | 8.5 - 10.5 | mg/dL |
| Sodium [Moles/volume] in Blood | 144.0 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Blood | 4.8 | 3.5 - 5.1 | mmol/L |
| Chloride [Moles/volume] in Blood | 109.0 | 98 - 110 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Blood | 24.8 | 22 - 29 | mmol/L |
Device Use
| Device | Date (since) |
|---|---|
| Appliance for sleep apnea (physical object) | 27-Aug-2022 |
| Blood glucose meter (physical object) | 26-Oct-2004 |
| Home nebulizer (physical object) | 01-Apr-1975 |